Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis

Neuroscience Letters

Volumn 287, Issue 1, 2000, Pages 17-20

  Pahan, Kalipada ^a   Schmid, Marian ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Experimental allergic encephalomyelitis; Nuclear factor kB; Pyrrolidine dithiocarbamate; Spinal cord

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL CULTURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; DNA BINDING; ELECTROPHORETIC MOBILITY; FEMALE; INFLAMMATION; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MULTIPLE SCLEROSIS; NF-KAPPA B; PYRROLIDINES; RATS; RATS, INBRED LEW; SPINAL CORD; THIOCARBAMATES;

EID: 0034674520     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01167-8     Document Type: Article

References (16)

1. Baeuerle P.A., Baltimore D. NF-kB: ten years after. Cell. 87:1996;13-20.
2. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kB. Nature. 376:1995;167-170.
3. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., Robert P., Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18:1998;3251-3260.
4. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P.A., Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest. 97:1996;1715-1722.
5. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 12:1994;139-153.
6. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
7. Kaltschmidt B., Baeuerle P.A., Kaltschmidt C. Potential involvement of the transcription factor NF-kB in neurological disorders. Mol. Aspects Med. 14:1993;171-190.
8. Martin R., McFarland H.F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32:1995;121-182.
9. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
10. Pahan K., Sheikh F.G., Namboodiri A.M.S., Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Invest. 100:1997;2671-2679.
11. 6 glial cells. J. Biol. Chem. 274:1999;7528-7536.
12. Raine C.S. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J. Neuroimmunol. 77:1997;135-152.
13. Sharief M.K., Phil M., Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325:1991;467-472.
14. Shields D.C., Tyor W.R., Deibler G.E., Hogan E.L., Banik N.L. Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA. 95:1998;5768-5772.
15. Stanislaus R., Pahan K., Singh A.K., Singh I. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. Neurosci. Lett. 269:1999;71-74.
16. Xie Q-W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.